These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 32035419)

  • 1. Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.
    Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
    Aging (Albany NY); 2020 Feb; 12(3):3095-3113. PubMed ID: 32035419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming energetic metabolism in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Life Sci; 2018 Jan; 193():141-152. PubMed ID: 29079469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling in Alzheimer's disease: up or down, that is the question.
    Boonen RA; van Tijn P; Zivkovic D
    Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β1 Restores Hippocampal Synaptic Plasticity and Memory in Alzheimer Model via the PI3K/Akt/Wnt/β-Catenin Signaling Pathway.
    Hu Y; Chen W; Wu L; Jiang L; Liang N; Tan L; Liang M; Tang N
    J Mol Neurosci; 2019 Jan; 67(1):142-149. PubMed ID: 30539409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer's Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway.
    Machhi J; Sinha A; Patel P; Kanhed AM; Upadhyay P; Tripathi A; Parikh ZS; Chruvattil R; Pillai PP; Gupta S; Patel K; Giridhar R; Yadav MR
    Neurotox Res; 2016 May; 29(4):495-513. PubMed ID: 26797524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/β-catenin pathway.
    Tiwari SK; Agarwal S; Seth B; Yadav A; Nair S; Bhatnagar P; Karmakar M; Kumari M; Chauhan LK; Patel DK; Srivastava V; Singh D; Gupta SK; Tripathi A; Chaturvedi RK; Gupta KC
    ACS Nano; 2014 Jan; 8(1):76-103. PubMed ID: 24467380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells.
    Zhang X; Yin WK; Shi XD; Li Y
    Eur J Pharm Sci; 2011 Apr; 42(5):540-6. PubMed ID: 21352912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icariin ameliorates glycolytic dysfunction in Alzheimer's disease models by activating the Wnt/β-catenin signaling pathway.
    Liu J; Wei AH; Liu TT; Ji XH; Zhang Y; Yan F; Chen MX; Hu JB; Zhou SY; Shi JS; Jin H; Jin F
    FEBS J; 2024 May; 291(10):2221-2241. PubMed ID: 38400523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target.
    Inestrosa NC; Varela-Nallar L; Grabowski CP; Colombres M
    IUBMB Life; 2007; 59(4-5):316-21. PubMed ID: 17505971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma.
    Vallée A; Lecarpentier Y
    Front Neurosci; 2016; 10():459. PubMed ID: 27807401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease.
    Jin N; Zhu H; Liang X; Huang W; Xie Q; Xiao P; Ni J; Liu Q
    Exp Neurol; 2017 Nov; 297():36-49. PubMed ID: 28711506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.
    Liu L; Wan W; Xia S; Kalionis B; Li Y
    Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanoma.
    Biechele TL; Camp ND; Fass DM; Kulikauskas RM; Robin NC; White BD; Taraska CM; Moore EC; Muster J; Karmacharya R; Haggarty SJ; Chien AJ; Moon RT
    Chem Biol; 2010 Nov; 17(11):1177-82. PubMed ID: 21095567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
    Matthews DC; Mao X; Dowd K; Tsakanikas D; Jiang CS; Meuser C; Andrews RD; Lukic AS; Lee J; Hampilos N; Shafiian N; Sano M; David Mozley P; Fillit H; McEwen BS; Shungu DC; Pereira AC
    Brain; 2021 Dec; 144(12):3742-3755. PubMed ID: 34145880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic postconditioning activates the Wnt/β-catenin pathway and protects against transient global cerebral ischemia through Dkk1 Inhibition and GSK-3β inactivation.
    Zhan L; Liu D; Wen H; Hu J; Pang T; Sun W; Xu E
    FASEB J; 2019 Aug; 33(8):9291-9307. PubMed ID: 31120770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine contributes to the neural stem cells fate against toxicity of microglial-derived factors induced by Aβ via the Wnt/β-catenin pathway.
    Jiang DQ; Wei MD; Wang KW; Lan YX; Zhu N; Wang Y
    Int J Neurosci; 2016; 126(3):257-68. PubMed ID: 26001208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT/β-catenin Pathway: a Possible Link Between Hypertension and Alzheimer's Disease.
    Vallée A; Vallée JN; Lecarpentier Y
    Curr Hypertens Rep; 2022 Oct; 24(10):465-475. PubMed ID: 35788966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma.
    Vallée A; Lecarpentier Y; Vallée JN
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CXXC5 function rescues Alzheimer's disease phenotypes by restoring Wnt/β-catenin signaling pathway.
    Yoon M; Kim H; Shin H; Lee H; Kang MJ; Park SH; Han G; Kim Y; Choi KY
    Pharmacol Res; 2023 Aug; 194():106836. PubMed ID: 37355147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.